Phoenix Biotech Acquisition Corp.
PBAX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $7 | $3 | $291 | $291 |
| - Cash | $2 | $3 | $5 | $3 |
| + Debt | $1 | $1 | $1 | $2 |
| Enterprise Value | $6 | $1 | $287 | $289 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$4 | -$5 | -$5 | -$8 |
| % Margin | – | – | – | – |
| Net Income | -$12 | -$30 | -$5 | -$9 |
| % Margin | – | – | – | – |
| EPS Diluted | -9.1 | -61.71 | -0.11 | -0.18 |
| % Growth | 85.3% | -56,000% | 38.9% | – |
| Operating Cash Flow | -$3 | -$5 | -$4 | -$4 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$3 | -$5 | -$4 | -$4 |